{"AllianceGenome": "5475", "HGNC": "5475", "MIM": "146735", "_id": "3489", "_version": 1, "accession": {"genomic": ["AC073573.27", "AF297519.1", "AJ006952.1", "AY443494.1", "CH471054.1", "CP068266.2", "CS138156.1", "NC_000012.12", "NC_060936.1"], "protein": ["AAA88070.1", "AAB06187.1", "AAG37059.1", "AAH03507.1", "AAH05007.1", "AAH10162.1", "AAH11708.1", "AAR05445.1", "BAG35976.1", "CAA07346.1", "CAG46590.1", "CAJ21554.1", "EAW96664.1", "NP_002169.1", "P24592.1", "XP_047284742.1", "XP_054227929.1"], "rna": ["AK313158.1", "BC003507.1", "BC005007.1", "BC010162.2", "BC011708.2", "BQ925731.1", "CB048388.1", "CR541791.1", "M62402.1", "M69054.1", "NM_002178.3", "XM_047428786.1", "XM_054371954.1"], "translation": [{"protein": "AAH10162.1", "rna": "BC010162.2"}, {"protein": "BAG35976.1", "rna": "AK313158.1"}, {"protein": "AAH11708.1", "rna": "BC011708.2"}, {"protein": "AAB06187.1", "rna": "M62402.1"}, {"protein": "AAH03507.1", "rna": "BC003507.1"}, {"protein": "NP_002169.1", "rna": "NM_002178.3"}, {"protein": "AAA88070.1", "rna": "M69054.1"}, {"protein": "XP_054227929.1", "rna": "XM_054371954.1"}, {"protein": "AAH05007.1", "rna": "BC005007.1"}, {"protein": "CAG46590.1", "rna": "CR541791.1"}, {"protein": "XP_047284742.1", "rna": "XM_047428786.1"}]}, "alias": "IBP6", "ensembl": {"gene": "ENSG00000167779", "protein": ["ENSP00000301464", "ENSP00000448953", "ENSP00000449344", "ENSP00000497776", "ENSP00000498200"], "transcript": ["ENST00000301464", "ENST00000548176", "ENST00000548547", "ENST00000549628", "ENST00000650247"], "translation": [{"protein": "ENSP00000448953", "rna": "ENST00000548547"}, {"protein": "ENSP00000301464", "rna": "ENST00000301464"}, {"protein": "ENSP00000449344", "rna": "ENST00000548176"}, {"protein": "ENSP00000498200", "rna": "ENST00000650247"}, {"protein": "ENSP00000497776", "rna": "ENST00000549628"}], "type_of_gene": "protein_coding"}, "entrezgene": "3489", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 8.50553397757, "exp_mis": 77.1167407629, "exp_syn": 31.7521496786, "lof_z": 1.86998607470134, "mis_z": 0.619183739516615, "mu_lof": 7.79602944949e-07, "mu_mis": 1.0028549964e-05, "mu_syn": 4.70775756777e-06, "n_lof": 3.0, "n_mis": 66.0, "n_syn": 33.0, "p_li": 0.0923313370768109, "p_null": 0.0386178383980072, "p_rec": 0.869050824525182, "syn_z": -0.137285689031486}, "bp": 723, "cds_end": 53495951, "cds_start": 53491501, "n_exons": 4, "nonpsych": {"exp_lof": 7.62917449596, "exp_mis": 69.7289394024, "exp_syn": 28.6696062117, "lof_z": 2.00151075827457, "mis_z": 0.768860241856451, "mu_lof": 7.79602944949e-07, "mu_mis": 1.0028549964e-05, "mu_syn": 4.70775756777e-06, "n_lof": 2.0, "n_mis": 57.0, "n_syn": 31.0, "p_li": 0.306290734425337, "p_null": 0.0221983208895414, "p_rec": 0.671510944685121, "syn_z": -0.274019347520509}, "nontcga": {"exp_lof": 7.81835087011, "exp_mis": 70.9406658795, "exp_syn": 29.2052395041, "lof_z": 2.05269106915203, "mis_z": 0.528849479407695, "mu_lof": 7.79602944949e-07, "mu_mis": 1.0028549964e-05, "mu_syn": 4.70775756777e-06, "n_lof": 2.0, "n_mis": 62.0, "n_syn": 28.0, "p_li": 0.302208955227513, "p_null": 0.0190119936154476, "p_rec": 0.678779051157039, "syn_z": 0.141210000111084}, "transcript": "ENST00000301464.3"}, "exons": [{"cdsend": 53102167, "cdsstart": 53097717, "chr": "12", "position": [[53097666, 53098051], [53100711, 53100857], [53101040, 53101160], [53102044, 53102340]], "strand": 1, "transcript": "NM_002178", "txend": 53102340, "txstart": 53097666}], "exons_hg19": [{"cdsend": 53495951, "cdsstart": 53491501, "chr": "12", "position": [[53491450, 53491835], [53494495, 53494641], [53494824, 53494944], [53495828, 53496124]], "strand": 1, "transcript": "NM_002178", "txend": 53496124, "txstart": 53491450}], "generif": [{"pubmed": 11914024, "text": "Inhibition of human osteoblast marker gene expression by retinoids is mediated in part by insulin-like growth factor binding protein-6."}, {"pubmed": 12006706, "text": "determination of blood levels in adult patients with severe liver disease before and after orthotopic liver transplantation"}, {"pubmed": 12558805, "text": "may function as an antiproliferative molecule suppressing mitogenic effects of insulin-like growth factors on Malassez cells"}, {"pubmed": 14710364, "text": "CCI-779 acts additively with IGFBP-6 to reduce rhabdomyosarcoma growth both in vitro and in vivo."}, {"pubmed": 15308688, "text": "C-domain of IGFBP-6 consists of a thyroglobulin type 1 fold comprising an alpha-helix followed by a loop, a three-stranded antiparallel beta-sheet incorporating a second loop, and a disulfide-bonded flexible third loop."}, {"pubmed": 15366928, "text": "A close correlation exists between residues of the carboxyl-terminal domain of IGFBP6 undergoing conformational change in 15N NMR spectroscopy studies with those that disappeared or broadened upon insulin-like growth factor (IGF-II) binding."}, {"pubmed": 15661050, "text": "The expression of certain IGFBP is significantly altered in renal cell carcinoma"}, {"pubmed": 15797461, "text": "The IGFBP-6 protein is synthesized as propeptides with a hydrophobic leader sequence, removal of which yields a mature protein composed of 3 recognizable domains of similar size."}, {"pubmed": 15889232, "text": "transgenic human IGFBP-6 mice may be considered a new tool for studies of the involvement of the brain IGF system in metabolism control and obesity."}, {"pubmed": 17519236, "text": "p38 MAPK is involved in IGFBP-6-induced IGF-independent rhabdomyosarcoma cell migration"}, {"pubmed": 17978469, "text": "Toxic effect of TCDD on osteogenesis through altering IGFBP6 gene expression in osteoblasts is reported."}, {"pubmed": 18039785, "text": "IGFBP-6 is translocated to the nucleus with functional consequences, and different members of the IGFBP family have specific nuclear import mechanisms."}, {"pubmed": 18395833, "text": "These studies provide evidence that overexpression of IGFBP-6 suppresses human and murine osteoblast differentiation, that IGFBP-6 and LMP-1 physically interact, and supports the conclusion that this interaction may be functionally relevant."}, {"pubmed": 18676680, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18724896, "text": "TCDD at low concentrations may have a negative effect on cell apoptosis and down-regulate gene expression of IGFBP-6 in SaOS-2 cells."}, {"pubmed": 18957410, "text": "bexarotene increased the occupancy of the identified enhancer element in IGFBP-6 gene by RXRalpha, RARbeta, cJun, cFos, and p300"}, {"pubmed": 18982452, "text": "Data show that an increase in JNK activation in the presence of NFkappaB inhibition significantly increased the expression of IGFBP6."}, {"pubmed": 18985860, "text": "IGFBP-6 is the effector of tumor suppressor activity of SEMA3B."}, {"pubmed": 19170196, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19453261, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19625176, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19692168, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19950226, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20432455, "text": "These results indicate that IGFBP-6 promotes Rh30 rhabdomyosarcoma chemotaxis in an IGF-independent manner, and that MAPK signaling pathways and their cross-talk play an important role in this process."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20634197, "text": "Meta-analysis of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20734064, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20810604, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21054968, "text": "Kininogen-1 and IGFBP-6 are expressed in serum and vitreous humor in proliferative vitreoretinopathy patients."}, {"pubmed": 21458526, "text": "IGFBP-6 inhibits osteoblastic differentiation mediated by vitamin d3 by directly binding the vitamin d receptor and inhibiting its function"}, {"pubmed": 21548981, "text": "The authors conclude that during hepatitis B/C virus infection, O-beta-GlcNAc of IGFBP-6 at Ser 204 diminish their binding with IGF-II, increase IGF-II cellular expression and promote cancer progression."}, {"pubmed": 21618524, "text": "These results suggest that the expression of IGFBP-6 in vascular endothelial cells is up-regulated by hypoxia and IGFBP-6 inhibits angiogenesis in vitro and in vivo"}, {"pubmed": 21820463, "text": "When IGFBP-6 gene expression was downregulated, cell proliferation was inhibited and apoptotic cell death was increased."}, {"pubmed": 21940310, "text": "Hh pathway is aberrant activation in colorectal carcinoma cell line. Its inhibitor may be effectual agent for colorectal cancer chemoprevention. Gli1 maintained cell survival by binding promoter regions and facilitating transcription of IGFBP6 and Bcl-2."}, {"pubmed": 21997736, "text": "IGFBP-6 acts as a inhibitory mediator of thyroid hormone effects in osteoblast differentiation"}, {"pubmed": 23126425, "text": "Review of the IGF system in physiology and disease with a focus on the regulation and actions of IGFBP-6, and its potential roles in cancer cells."}, {"pubmed": 23623986, "text": "This is the first report to implicate IGFBP-6 as a suppressor of cellular proliferation and IGF-II as an inducer of cellular contractility in this connective tissue disease."}, {"pubmed": 23808406, "text": "When the concentrations of IGFBP-6 or KNG1 were greater than 98.5 pg/ml or 88.5 ng/ml, respectively, they predicted the proliferative vitreoretinopathy prognosis."}, {"pubmed": 24003225, "text": "Data indicate that IGFBP-6 binds to prohibitin-2 on the cell membrane, and knockdown of the latter abrogates IGFBP-6-induced migration."}, {"pubmed": 24182837, "text": "Our results indicate that IGF2 and IGFBP6 appear to govern various regulatory feedback mechanisms in periodontal ligament cells"}, {"pubmed": 24379119, "text": "IGFBP6 attenuation in ACTH-secreting pituitary adenomas is associated with tumor growth, through activation of PI3K-AKT-mTOR pathway"}, {"pubmed": 24747338, "text": "CCL-18 and IGFBP-6 were identified as new potential serum biomarkers for prostate cancer."}, {"pubmed": 26039376, "text": "We found that IGFBP6 and SATB2 were significantly down-regulated in HIV-infected CEM*174 cells and 3 different cohorts of HIV/AIDS patients while their promoters were predominantly hyper-methylated compared with normal controls."}, {"pubmed": 26976474, "text": "This study thus investigated the relationship between IGFs-related proteins in diabetic patients and the incidence of colorectal carcinoma."}, {"pubmed": 27623076, "text": "Results suggest that insulin like growth factor binding protein 6 (IGFBP6) may be an independent prognostic biomarker for nasopharyngeal carcinoma (NPC)."}, {"pubmed": 27650075, "text": "IGFBP6 might be an important regulator and prognostic factor for glioma."}, {"pubmed": 28829625, "text": "We identified a novel SNP variant, Chr12:g.53494591T>C. c.T430C (p.S144P) in the insulin-like growth factor binding protein-6 (IGFBP6) gene. This variant was shared by all affected family members, but not by unaffected members. The c.T430C (p.S144P) variant of IGFBP6 was identified as the likely causal variant associated with increased risk of familial disc degeneration in the studied pedigree."}, {"pubmed": 29039467, "text": "These findings demonstrated that hMSCCMmediated neuroprotection was attributed to IGF1Rmediated signaling, potentiated via the inhibition of IGF2 by IGFBP6. The results of the present study provide insight into the mechanism by which hMSC administration may promote recovery from nerve injury."}, {"pubmed": 29439316, "text": "IGFBP-6 could inhibit invasion and migration of colorectal carcinoma cells"}, {"pubmed": 29577195, "text": "A decrease of IGFBP6 expression can involve a decrease in the expression of N-cadherin and transcription factor Slug."}, {"pubmed": 30117676, "text": "IGFBP-6 seems to play an important role in the control of cell-specific immunologic adaptation following hyperthermia. (Review)"}, {"pubmed": 30231881, "text": "IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling"}, {"pubmed": 32037372, "text": "IGFBP6 Is Downregulated in Unstable Carotid Atherosclerotic Plaques According to an Integrated Bioinformatics Analysis and Experimental Verification."}, {"pubmed": 32156471, "text": "Decreased expression of IGFBP6 correlates with poor survival in colorectal cancer patients."}, {"pubmed": 34396926, "text": "The clinical characteristics and prognostic value of IGFBP6 in glioma."}, {"pubmed": 35430273, "text": "MAFB promotes the malignant phenotypes by IGFBP6 in esophageal squamous cell carcinomas."}, {"pubmed": 35457175, "text": "IGFBP-6: At the Crossroads of Immunity, Tissue Repair and Fibrosis."}, {"pubmed": 35654889, "text": "Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma."}, {"pubmed": 36946206, "text": "Evaluation of SNPs from human IGFBP6 associated with gene expression: an in-silico study."}, {"pubmed": 37336811, "text": "Effect of IGFBP6 Knockdown on Proteins Regulating Exosome Synthesis and Secretion in MDA-MB-231 Cell Line."}], "genomic_pos": {"chr": "12", "end": 53102345, "ensemblgene": "ENSG00000167779", "start": 53097436, "strand": 1}, "genomic_pos_hg19": {"chr": "12", "end": 53496129, "start": 53491220, "strand": 1}, "go": {"BP": [{"evidence": "NAS", "gocategory": "BP", "id": "GO:0007165", "pubmed": 10087296, "qualifier": "involved_in", "term": "signal transduction"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0008285", "pubmed": 7539002, "qualifier": "involved_in", "term": "negative regulation of cell population proliferation"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0016477", "pubmed": 24003225, "qualifier": "involved_in", "term": "cell migration"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0032874", "pubmed": 24003225, "qualifier": "involved_in", "term": "positive regulation of stress-activated MAPK cascade"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0043410", "pubmed": 24003225, "qualifier": "involved_in", "term": "positive regulation of MAPK cascade"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0043567", "qualifier": "involved_in", "term": "regulation of insulin-like growth factor receptor signaling pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0090090", "pubmed": 24431302, "qualifier": "involved_in", "term": "negative regulation of canonical Wnt signaling pathway"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005615", "qualifier": "is_active_in", "term": "extracellular space"}, {"evidence": "IMP", "gocategory": "CC", "id": "GO:0042568", "pubmed": 15308688, "qualifier": "part_of", "term": "insulin-like growth factor binary complex"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0001968", "qualifier": "enables", "term": "fibronectin binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0005102", "pubmed": 24431302, "qualifier": "enables", "term": "signaling receptor binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [24003225, 32296183], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0031994", "qualifier": "enables", "term": "insulin-like growth factor I binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0031995", "qualifier": "enables", "term": "insulin-like growth factor II binding"}, {"category": "MF", "evidence": "IMP", "id": "GO:0031995", "pubmed": 15308688, "qualifier": "enables", "term": "insulin-like growth factor II binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": 32296183, "qualifier": "enables", "term": "identical protein binding"}]}, "homologene": {"genes": [[9598, 451929], [9606, 3489], [9615, 607374], [9913, 404186], [10090, 16012], [10116, 25641]], "id": 1641}, "interpro": [{"desc": "Thyroglobulin type-1", "id": "IPR000716", "short_desc": "Thyroglobulin_1"}, {"desc": "Insulin-like growth factor-binding protein family 1-6, chordata", "id": "IPR022321", "short_desc": "IGFBP_1-6_chordata"}, {"desc": "Insulin-like growth factor-binding protein 6", "id": "IPR022326", "short_desc": "IGFBP-6"}, {"desc": "Thyroglobulin type-1 superfamily", "id": "IPR036857", "short_desc": "Thyroglobulin_1_sf"}, {"desc": "Insulin-like growth factor-binding protein, IGFBP", "id": "IPR000867", "short_desc": "IGFBP-like"}, {"desc": "Growth factor receptor cysteine-rich domain superfamily", "id": "IPR009030", "short_desc": "Growth_fac_rcpt_cys_sf"}], "ipi": ["IPI00029235", "IPI01022291", "IPI01022800"], "map_location": "12q13.13", "name": "insulin like growth factor binding protein 6", "other_names": ["IBP-6", "IGF binding protein 6", "IGFBP-6", "insulin-like growth factor-binding protein 6"], "pantherdb": {"HGNC": "5475", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "96441", "ortholog_type": "LDO", "panther_family": "PTHR11551", "taxid": 10090, "uniprot_kb": "P47880"}, {"RGD": "2877", "ortholog_type": "LDO", "panther_family": "PTHR11551", "taxid": 10116, "uniprot_kb": "P35572"}, {"Ensembl": "ENSGALG00000037940", "ortholog_type": "O", "panther_family": "PTHR11551", "taxid": 9031, "uniprot_kb": "A0A1D5PRP9"}, {"ZFIN": "ZDB-GENE-090521-1", "ortholog_type": "O", "panther_family": "PTHR11551", "taxid": 7955, "uniprot_kb": "A0A2R8QKX9"}, {"ZFIN": "ZDB-GENE-090521-2", "ortholog_type": "O", "panther_family": "PTHR11551", "taxid": 7955, "uniprot_kb": "F6N9E8"}, {"ZFIN": "ZDB-GENE-040412-1", "ortholog_type": "O", "panther_family": "PTHR11551", "taxid": 7955, "uniprot_kb": "Q66I28"}], "uniprot_kb": "P24592"}, "pathway": {"reactome": [{"id": "R-HSA-381426", "name": "Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}], "wikipathways": {"id": "WP289", "name": "Myometrial relaxation and contraction pathways"}}, "pdb": ["1RMJ", "2JM2"], "pfam": "PF00086", "pharmgkb": "PA29708", "pharos": {"target_id": 8143, "tdl": "Tchem"}, "pir": ["A39842", "S05699"], "prosite": ["PS51162", "PS51323"], "reagent": {"CM-LibrX-no-seq": [{"id": "GNF325940", "relationship": "is"}, {"id": "GNF325941", "relationship": "is"}, {"id": "GNF325942", "relationship": "is"}], "GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF167896", "relationship": "is"}, {"id": "GNF178802", "relationship": "is"}, {"id": "GNF189708", "relationship": "is"}, {"id": "GNF200614", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF006968", "relationship": "is"}, {"id": "GNF006969", "relationship": "is"}, {"id": "GNF006970", "relationship": "is"}, {"id": "GNF006971", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": {"id": "GNF285568", "relationship": "is"}, "MasterSecretomicsList": [{"id": "GNF330522", "relationship": "is"}, {"id": "GNF332200", "relationship": "is"}, {"id": "GNF333795", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF334759", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF100430", "relationship": "is"}, {"id": "GNF140085", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000012.12", "NC_060936.1"], "protein": ["NP_002169.1", "XP_047284742.1", "XP_054227929.1"], "rna": ["NM_002178.3", "XM_047428786.1", "XM_054371954.1"], "translation": [{"protein": "NP_002169.1", "rna": "NM_002178.3"}, {"protein": "XP_054227929.1", "rna": "XM_054371954.1"}, {"protein": "XP_047284742.1", "rna": "XM_047428786.1"}]}, "reporter": {"HG-U133_Plus_2": "203851_at", "HG-U95Av2": "1736_at", "HTA-2_0": "TC12000428.hg.1", "HuEx-1_0": "3415744", "HuGene-1_1": "7955694", "HuGene-2_1": "16751655"}, "summary": "Enables identical protein binding activity and insulin-like growth factor II binding activity. Involved in cell migration and positive regulation of stress-activated MAPK cascade. Part of insulin-like growth factor binary complex. Implicated in obesity. Biomarker of breast cancer; in situ carcinoma; leiomyoma; and neovascular inflammatory vitreoretinopathy. [provided by Alliance of Genome Resources, Apr 2022]", "symbol": "IGFBP6", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1367148"}, "unigene": "Hs.274313", "uniprot": {"Swiss-Prot": "P24592", "TrEMBL": ["F8VVA5", "A0A3B3IUE0", "F8VYK9"]}, "wikipedia": {"url_stub": "IGFBP6"}}